Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)

Sep 15,2023 | Consortium_staff Funding Opportunities

Posted by: NCI
Post date: September 1, 2022
Applications due: March 2, 2024

This funding opportunity announcement (FOA) establishes an accelerated review/award process to support research to understand health outcomes related to an unexpected and/or time-sensitive event (e.g., emergent environmental threat; pandemic; change in local, state, or national policy; natural disaster). Applications in response to this FOA must demonstrate that the research proposed is time sensitive and must be initiated with minimum delay due to a limited window of opportunity to collect baseline data, answer key research questions, and/or prospectively evaluate a new policy or program. This FOA is intended to support opportunities in which empirical study could only be available through expedited review and funding, necessitating a substantially shorter process than the typical National Institutes of Health grant review/award cycle. The time from submission to award is expected to occur within 4–5 months. However, administrative requirements and other unforeseen circumstances may delay issuance dates beyond that timeline.

Applications are being accepted on a rolling basis.

For more information, view the posting.